---
schema_version: "secwatch.filing_event.v1"
accession: "0000313143-22-000020"
form_type: "8-K"
ticker: "HAE"
cik: "0000313143"
company_name: "HAEMONETICS CORP"
filed_at: "2022-05-10T23:59:59+00:00"
generated_at: "2026-06-25T22:02:45.563930+00:00"
event_type: "earnings"
sentiment: "neutral"
materiality_score: 0.25
calibrated_materiality_score: 0.25
confidence: "low"
source: SEC EDGAR
---

# Haemonetics issues Q4 FY2022 earnings press release; details not available in filing text

## Summary
- Press release dated May 10, 2022, furnished as Exhibit 99.1, covers Q4 and full year ended April 2, 2022.
- Specific financial results (revenue, EPS, guidance) are not included in the 8-K or appended exhibit text provided.
- No material updates beyond the fact of the earnings release can be confirmed from the filing alone.

## SEC filing metadata
- accession: 0000313143-22-000020
- form_type: 8-K
- ticker: HAE
- cik: 0000313143
- company_name: HAEMONETICS CORP
- filed_at: 2022-05-10T23:59:59+00:00
- event_type: earnings
- sentiment: neutral
- materiality_score: 0.25
- calibrated_materiality_score: 0.25
- confidence: low
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/313143/000031314322000020/0000313143-22-000020-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/313143/000031314322000020/hae-20220510.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000313143-22-000020
- JSON: https://secwatch.observer/filing/0000313143-22-000020.json
- Plain text: https://secwatch.observer/filing/0000313143-22-000020.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.